Yujin Kim

发表

Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer.

Y. Shim, Joungho Han, Joobae Park, 2009, Cancer letters.

CpG island hypermethylation as a biomarker for the early detection of lung cancer.

Duk-Hwan Kim, Yujin Kim, 2015, Methods in molecular biology.

Negative E ﬀ ect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer

Y. Shim, Joungho Han, Wun-Jae Kim, 2020 .

Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer

E. Cho, Y. Shim, Joungho Han, 2020, Journal of clinical medicine.

Overexpression of &bgr;‐Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA–IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy

E. Cho, Y. Shim, Joungho Han, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro

Y. Shim, Joungho Han, Duk-Hwan Kim, 2015, BMC Cancer.

Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence‐related prognostic indicator in stage I esophageal squamous cell carcinoma

Y. Shim, Joobae Park, Duk-Hwan Kim, 2013, Cancer.

RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung

E. Cho, Y. Shim, Joungho Han, 2015, Clinical Epigenetics.

Imaging , Diagnosis , Prognosis Association of RASSF 1 A and p 63 with Poor Recurrence-Free Survival in Node-Negative Stage I – II Non – Small Cell Lung Cancer

E. Cho, Y. Shim, Joobae Park, 2013 .

Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer.

E. Cho, Y. Shim, Joobae Park, 2012, Lung cancer.

HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non‐small cell lung cancer

Y. Shim, Joungho Han, Duk-Hwan Kim, 2015, Molecular carcinogenesis.

Aberrant Methylation of SLIT2 Gene in Plasma Cell-Free DNA of Non-Small Cell Lung Cancer Patients

Y. Shim, Joungho Han, Dongho Kim, 2022, Cancers.

Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer

E. Cho, Y. Shim, Joungho Han, 2020, Journal of clinical medicine.

Genome-wide analysis of DNA methylation in bronchial washings

Y. Shim, Joungho Han, Hojoong Kim, 2018, Clinical epigenetics.

Epigenetic Inactivation of Heparan Sulfate (Glucosamine) 3-O-Sulfotransferase 2 in Lung Cancer and Its Role in Tumorigenesis

Y. Shim, Joungho Han, Ji-Youn Han, 2013, PloS one.

HOXA11 hypermethylation is associated with progression of non-small cell lung cancer

Y. Shim, Joungho Han, Duk-Hwan Kim, 2013, Oncotarget.

Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells

Y. Shim, Joungho Han, Duk-Hwan Kim, 2017, Oncotarget.

Promoter Hypermethylation of the p16 Gene Is Associated with Poor Prognosis in Recurrent Early-Stage Hepatocellular Carcinoma

Joobae Park, Duk-Hwan Kim, C. Park, 2008, Cancer Epidemiology Biomarkers & Prevention.

Promoter Hypermethylation of the p 16 Gene Is Associated with Poor Prognosis in Recurrent Early-Stage Hepatocellular Carcinoma

Joobae Park, Duk-Hwan Kim, C. Park, 2008 .

A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma

X. Wang, E. Bowman, S. Ambs, 2020, Cell.

Metformin and tenovin‐6 synergistically induces apoptosis through LKB1‐independent SIRT1 down‐regulation in non‐small cell lung cancer cells

E. Cho, Y. Shim, Joungho Han, 2019, Journal of cellular and molecular medicine.

Association of Global Levels of Histone Modifications with Recurrence-Free Survival in Stage IIB and III Esophageal Squamous Cell Carcinomas

E. Cho, Y. Shim, Joungho Han, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells

Y. Shim, Joungho Han, Dongho Kim, 2020 .

Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells

Y. Shim, Joungho Han, Dongho Kim, 2023, Clinical Epigenetics.

Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro

Y. Shim, Joungho Han, Duk-Hwan Kim, 2015, BMC Cancer.

Synergistic Effect of Bcl-2 and Cyclin A2 on Adverse Recurrence-Free Survival in Stage I Non-small Cell Lung Cancer

E. Cho, Y. Shim, Joobae Park, 2013, Annals of surgical oncology.

Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer

Y. Shim, Joungho Han, Hojoong Kim, 2017, Clinical Epigenetics.

Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells

Y. Shim, Joungho Han, Dongho Kim, 2021, Cancers.

A functional single nucleotide polymorphism at the promoter region of cyclin A2 is associated with increased risk of colon, liver, and lung cancers

Y. Shim, Joobae Park, Duk-Hwan Kim, 2011, Cancer.

Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer

Y. Shim, Joungho Han, Hojoong Kim, 2017, Clinical Epigenetics.

Genomic alterations of ground-glass nodular lung adenocarcinoma

D. Hayes, Y. Shim, W. Park, 2018, Scientific reports.

Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer

E. Cho, Joobae Park, Duk-Hwan Kim, 2010, Breast Cancer Research.

Genome-wide analysis of DNA methylation in bronchial washings

Y. Shim, Joungho Han, Hojoong Kim, 2018, Clinical Epigenetics.